These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 12089281

  • 1. Evaluation of the C6 peptide enzyme-linked immunosorbent assay for individuals vaccinated with the recombinant OspA vaccine.
    Marques AR, Martin DS, Philipp MT.
    J Clin Microbiol; 2002 Jul; 40(7):2591-3. PubMed ID: 12089281
    [Abstract] [Full Text] [Related]

  • 2. Recombinant assay for serodiagnosis of Lyme disease regardless of OspA vaccination status.
    Gomes-Solecki MJ, Wormser GP, Schriefer M, Neuman G, Hannafey L, Glass JD, Dattwyler RJ.
    J Clin Microbiol; 2002 Jan; 40(1):193-7. PubMed ID: 11773115
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease.
    Ledue TB, Collins MF, Young J, Schriefer ME.
    Clin Vaccine Immunol; 2008 Dec; 15(12):1796-804. PubMed ID: 18945880
    [Abstract] [Full Text] [Related]

  • 4. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA.
    Koide S, Yang X, Huang X, Dunn JJ, Luft BJ.
    J Mol Biol; 2005 Jul 08; 350(2):290-9. PubMed ID: 15935380
    [Abstract] [Full Text] [Related]

  • 5. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE.
    Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN, Philipp MT.
    J Clin Microbiol; 1999 Dec 08; 37(12):3990-6. PubMed ID: 10565920
    [Abstract] [Full Text] [Related]

  • 6. A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum.
    Wagner B, Freer H, Rollins A, Erb HN.
    Vet Immunol Immunopathol; 2011 Apr 15; 140(3-4):190-8. PubMed ID: 21208663
    [Abstract] [Full Text] [Related]

  • 7. Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
    Izac JR, Oliver LD, Earnhart CG, Marconi RT.
    Vaccine; 2017 May 31; 35(24):3178-3185. PubMed ID: 28479174
    [Abstract] [Full Text] [Related]

  • 8. Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi.
    O'Connor TP, Esty KJ, Hanscom JL, Shields P, Philipp MT.
    Clin Diagn Lab Immunol; 2004 May 31; 11(3):458-62. PubMed ID: 15138170
    [Abstract] [Full Text] [Related]

  • 9. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.
    Scheckelhoff MR, Telford SR, Hu LT.
    Vaccine; 2006 Mar 10; 24(11):1949-57. PubMed ID: 16300863
    [Abstract] [Full Text] [Related]

  • 10. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.
    Fawcett PT, Rose CD, Budd SM, Gibney KM.
    Clin Diagn Lab Immunol; 2001 Jan 10; 8(1):79-84. PubMed ID: 11139199
    [Abstract] [Full Text] [Related]

  • 11. Improved Serodiagnostic Performance for Lyme Disease by Use of Two Recombinant Proteins in Enzyme-Linked Immunosorbent Assay Compared to Standardized Two-Tier Testing.
    Bradshaw GL, Thueson RK, Uriona TJ.
    J Clin Microbiol; 2017 Oct 10; 55(10):3046-3056. PubMed ID: 28768731
    [Abstract] [Full Text] [Related]

  • 12. Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA.
    Eschner AK, Mugnai K.
    Parasit Vectors; 2015 Feb 10; 8():92. PubMed ID: 25890386
    [Abstract] [Full Text] [Related]

  • 13. Reservoir targeted vaccine for lyme borreliosis induces a yearlong, neutralizing antibody response to OspA in white-footed mice.
    Meirelles Richer L, Aroso M, Contente-Cuomo T, Ivanova L, Gomes-Solecki M.
    Clin Vaccine Immunol; 2011 Nov 10; 18(11):1809-16. PubMed ID: 21918116
    [Abstract] [Full Text] [Related]

  • 14. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
    Molloy PJ, Berardi VP, Persing DH, Sigal LH.
    Clin Infect Dis; 2000 Jul 10; 31(1):42-7. PubMed ID: 10913394
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of OspA vaccination-induced serological correlates of protection against Lyme borreliosis in a mouse model.
    Schwendinger MG, O'Rourke M, Traweger A, Savidis-Dacho H, Pilz A, Portsmouth D, Livey I, Barrett PN, Crowe BA.
    PLoS One; 2013 Jul 10; 8(11):e79022. PubMed ID: 24260146
    [Abstract] [Full Text] [Related]

  • 16. Seroprevalence of Borrelia burgdorferi-specific C6 antibody in dogs before and after implementation of a nonadjuvanted recombinant outer surface protein A vaccine in a Rhode Island small animal clinic.
    Hebert D, Eschner A.
    Vet Ther; 2010 Jul 10; 11(3):E1-9. PubMed ID: 20960414
    [Abstract] [Full Text] [Related]

  • 17. Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.
    LaFleur RL, Dant JC, Wasmoen TL, Callister SM, Jobe DA, Lovrich SD, Warner TF, Abdelmagid O, Schell RF.
    Clin Vaccine Immunol; 2009 Feb 10; 16(2):253-9. PubMed ID: 19052162
    [Abstract] [Full Text] [Related]

  • 18. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
    Grosenbaugh DA, De Luca K, Durand PY, Feilmeier B, DeWitt K, Sigoillot-Claude C, Sajous ML, Day MJ, David F.
    BMC Vet Res; 2018 Oct 16; 14(1):312. PubMed ID: 30326885
    [Abstract] [Full Text] [Related]

  • 19. Development of novel multi-protein chimeric immunogens that protect against infection with the Lyme disease agent, Borreliella burgdorferi.
    O'Bier NS, Camire AC, Patel DT, Billingsley JS, Hodges KR, Marconi RT.
    mBio; 2024 Oct 16; 15(10):e0215924. PubMed ID: 39287439
    [Abstract] [Full Text] [Related]

  • 20. Design, construction and evaluation of multi-epitope antigens for diagnosis of Lyme disease.
    Schreterova E, Bhide M, Potocnakova L, Borszekova Pulzova L.
    Ann Agric Environ Med; 2017 Dec 23; 24(4):696-701. PubMed ID: 29284249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.